|
|
|
Volumn 20, Issue 3-4, 2000, Pages 61-64
|
|
Prevention with clodronate of osteoporosis secondary to inhaled corticosteroid treatment in patients with chronic asthmatic bronchitis
a
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKALINE PHOSPHATASE;
BECLOMETASONE;
BECLOMETASONE DIPROPIONATE;
BISPHOSPHONIC ACID DERIVATIVE;
CALCITONIN;
CALCIUM;
CLODRONIC ACID;
CORTICOSTEROID;
ESTROGEN;
ETIDRONIC ACID;
FLUORIDE;
FLUTICASONE;
FLUTICASONE PROPIONATE;
PHOSPHORUS;
TESTOSTERONE;
VITAMIN D;
ADULT;
AGED;
ARTICLE;
ASTHMA;
BONE ATROPHY;
BONE DENSITY;
BONE MASS;
BONE MINERAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
HUMAN;
HYDROXYPROLINE URINE LEVEL;
MAJOR CLINICAL STUDY;
MALE;
OSTEOPOROSIS;
PHOSPHATE BLOOD LEVEL;
PHOSPHATURIA;
RANDOMIZED CONTROLLED TRIAL;
STEROID THERAPY;
TREATMENT OUTCOME;
ADMINISTRATION, INHALATION;
AGED;
ANDROSTADIENES;
ANTI-ASTHMATIC AGENTS;
ASTHMA;
BECLOMETHASONE;
BONE DENSITY;
CHRONIC DISEASE;
CLODRONIC ACID;
HUMANS;
INFUSION PUMPS;
MALE;
MIDDLE AGED;
OSTEOPOROSIS;
|
|
EID: 0034457933
PISSN: 02511649
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (10)
|
|
References (15)
|
